- Egészségügy
Healthcare & Life Sciences Blog - Baker McKenzie
Legal and regulatory insights for the Healthcare and Life Sciences industry.
Bemutatkozás
This entity operates as a specialized blog providing in-depth legal and regulatory analysis concerning the Healthcare and Life Sciences industries. The content covers specific areas such as Pharmaceuticals & Biotech, Medical Devices, Digital Health, and broader Healthcare Services, often detailing legislative changes like the US BIOSECURE Act, EU Biotech Act, and EU Pharmaceutical Package reforms. The blog also addresses supply chain dynamics, pricing and reimbursement reforms (e.g., in Hungary), and data privacy issues like the European Health Data Space (EHDS). It features articles authored by various legal professionals from Baker McKenzie, covering both US and EU regulatory landscapes. The focus is on informing stakeholders about compliance, market access, and legislative shifts.
Szolgáltatások, tevékenységek
- Publication of analysis on the US BIOSECURE Act implications
- Publication of best practices for Manufacturing Site Divestitures
- Publication of analysis on Medical Device AI regulation in the EU
- Publication of analysis on the EU Biotech Act
- Publication of analysis on the EU’s proposal to simplify Medical and In-Vitro-Diagnostic Devices Regulations (MDR/IVDR)
- Publication of analysis on the EU Pharma Package political deal
- Publication of analysis on Healthcare & Life Sciences Supply Chains opportunities
- Publication of analysis on Healthcare & Life Sciences Supply Chains stability
- Publication of analysis on the EU Pharmaceutical Legislation revision proposal
- Publication of analysis on EU Pharma Package impact on Orphan Medicines
- Publication of analysis on Hungarian Pricing and Reimbursement Reforms
- Publication of analysis on Member States’ first reactions to the EU Pharmaceutical Package
- Publication of analysis on Eco Measures embedded into EU Reform Proposals
- Publication of analysis on Supply Chain Protection in EU Reform Proposals
- Publication of analysis on OIG advisory opinion regarding healthcare services financial arrangements
- Publication of analysis on German healthcare policy agenda implications
- Publication of analysis on Hungarian named patient reimbursement changes
- Publication of analysis on the European Health Data Space (EHDS) impact
- Publication of analysis on EU sanctions on Russia and Belarus affecting life sciences
- Publication of analysis on the evolving legal landscape for psychedelics in the UK
- Publication of analysis on the Commission’s Implementing Act on Joint Clinical Assessments for medicines
- Publication of analysis on US life sciences legal framework developments in 2023
- Publication of analysis on the French Social Security Financing Bill for 2024 (LFSS)
- Publication of analysis on European Commission communication regarding critical medicine shortages